Skip to content
Screener

Fulgent Genetics, Inc. FLGT Therapeutic Development — Indefinite Lived Intangible Assets Excluding Goodwill

Similar metrics at other companies

Restoration Hardware logo
RHRH — Indefinite Lived Intangible Assets Excluding Goodwill
$62.97M+1.5%
Restoration Hardware logo
RHWaterworks — Indefinite Lived Intangible Assets Excluding Goodwill
$17M0.0%
Hain Celestial Group logo
HAINInternational — Indefinite Lived Intangible Assets Excluding Goodwill
$37.34M
Martin Marietta Materials logo
MLMSpecialties — Indefinite Lived Intangible Assets Excluding Goodwill
$7M+250%
Woodward logo
WWDIndustrial — Indefinite Lived Intangible Assets Excluding Goodwill
$66.47M+5.9%
B&G Foods logo
BGSMeals — Indefinite Lived Intangible Assets Excluding Goodwill
$266.06M+21.1%

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$526.64M-16.5%
Enterprise value$511.45M-6.7%
P/S1.6×-0.4×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill.

The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 7:08 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-199065
Line itemMarch 31, 2026December 31, 2025
Total current assets479,042550,490
Marketable securities, long-term328,287369,269
Fixed assets, net116,344112,549
In-process research & development68,49068,490
Other intangible assets, net85,49964,791
Goodwill53,73125,080
Other long-term assets24,97622,856
Total assets$1,156,369$1,213,525

Item 1. Financial Statements.

FAQ

What is Fulgent Genetics, Inc.'s therapeutic development — indefinite lived intangible assets excluding goodwill?
Fulgent Genetics, Inc. (FLGT) reported therapeutic development — indefinite lived intangible assets excluding goodwill of $68.49M in Q1 2026.
How has Fulgent Genetics, Inc.'s therapeutic development — indefinite lived intangible assets excluding goodwill changed year-over-year?
Fulgent Genetics, Inc.'s therapeutic development — indefinite lived intangible assets excluding goodwill increased by 6.0% year-over-year, from $64.59M to $68.49M.
What does therapeutic development — indefinite lived intangible assets excluding goodwill mean?
Represents the value of intangible assets within the therapeutic development segment that are expected to provide cash flows indefinitely, such as certain trademarks or licenses. These assets are not amortized but are subject to annual impairment testing.

Ask your AI about Fulgent Genetics, Inc.'s therapeutic development — indefinite lived intangible assets excluding goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude